Pfizer inc. and OPKO Health Inc. announced today that the USFDA has accepted for filing the initial Biologics License Application for somatrogon, a long-acting ... Jan 05
Clinical Study proves weekly administration of Somatrogon more effective in treating human growth deficiency disease... Oct 09
-Advertisements-